<SEC-DOCUMENT>0001415889-25-011859-index.html : 20250502
<SEC-HEADER>0001415889-25-011859.hdr.sgml : 20250502
<ACCEPTANCE-DATETIME>20250502181916
ACCESSION NUMBER:		0001415889-25-011859
CONFORMED SUBMISSION TYPE:	4/A
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20250415
FILED AS OF DATE:		20250502
DATE AS OF CHANGE:		20250502

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			HALL WALLACE L JR
		CENTRAL INDEX KEY:			0001762801
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36279
		FILM NUMBER:		25910370

	MAIL ADDRESS:	
		STREET 1:		5956 SHERRY LN
		STREET 2:		1810
		CITY:			DALLAS
		STATE:			TX
		ZIP:			75225

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tvardi Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001346830
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				000000000
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		3 SUGAR CREEK CTR. BLVD.
		STREET 2:		STE 525
		CITY:			SUGAR LAND
		STATE:			TX
		ZIP:			77478
		BUSINESS PHONE:		(713) 489-8654

	MAIL ADDRESS:	
		STREET 1:		3 SUGAR CREEK CTR. BLVD.
		STREET 2:		STE 525
		CITY:			SUGAR LAND
		STATE:			TX
		ZIP:			77478

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cara Therapeutics, Inc.
		DATE OF NAME CHANGE:	20100721

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Cara Therapeutics Inc
		DATE OF NAME CHANGE:	20051213
</SEC-HEADER>
<DOCUMENT>
<TYPE>4/A
<SEQUENCE>1
<FILENAME>form4a-05022025_100513.xml
<TEXT>
Document 1 - file: form4a-05022025_100513.html

Document 1 - RAW XML: form4a-05022025_100513.xml

</DOCUMENT>
</SEC-DOCUMENT>